dr. finn on studies of pembrolizumab in hepatocellular carcinoma
Published 7 years ago • 316 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
1:34
dr. finn on results of resource study in liver cancer
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
2:09
dr. finn on finding a biomarker for patients with hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
2:13
richard s. finn, md, offers opinion on the role of frontline atezolizumab bevacizumab in hcc
-
1:09
keynote-224: improving hcc outcomes with pembrolizumab
-
2:18
dr. richard finn on the difficulties of treating liver cancer
-
3:02
keynote-224: second-line pembrolizumab’s value in hcc
-
2:11
dr. finn on the rationale for the phase iii keynote-240 trial in hcc
-
3:06
dr. finn on tivantinib and regorafenib for the treatment of liver cancer
-
1:27
dr. pinato on study of sorafenib in pretreated patients with hcc
-
2:19
the future of treatment in hepatocellular carcinoma
-
2:09
keynote-240: pembrolizumab in advanced hcc
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
1:57
dr. kaseb on the progression of hcc research
-
2:14
dr. finn recaps second-line advancements in hcc
-
1:38
dr. el-khoueiry discusses research on biomarkers in hcc